Medical Updates

Sacubitril/Valsartan for Treating Cancer Therapy-related Cardiac Dysfunction

Sacubitril/valsartan is recommended for patients with heart failure and reduced left ventricular ejection fraction (LVEF). Nevertheless, little is...

14 Feb, 2020

 
Email this page
Clopidogrel vs. Aspirin following Uneventful 12-month DAPT in AMI Patients Undergoing Drug-Eluting Stenting

The benefits of clopidogrel monotherapy following dual antiplatelet therapy (DAPT) have been less studied in acute myocardial infarction (AMI)...

06 Feb, 2020

 
Email this page
P2Y12 Inhibitors in Real-World STEMI Population: A First Head-to-Head Comparison on Efficacy and Safety

Amongst ST-segment elevation myocardial infarction (STEMI) patients, newer P2Y12 receptor inhibitors (prasugrel and ticagrelor) have more favorable...

03 Feb, 2020

 
Email this page
EPICOR Asia: Early Discontinuation of DAPT in NSTEMI Patients Warrants Intensive Monitoring during Long-term

A recent real-world study revealed that most of the non-ST segment elevation myocardial infarction patients (NSTEMI; 90%) were treated with dual...

29 Jan, 2020

 
Email this page

eCMEs

Date: 17th February 2020
Time: 3:00 pm to 4:00 pm

Key Trials

Prasugrel Renders Superior Efficacy vs. Ticagrelor in ACS Patients Undergoing Invasive Evaluation

According to the trial, prasugrel was associated with a greater reduction of composite of death, MI and stroke at one year without increased...

SMART-DATE Trial: Long-Term DAPT-The Standard of Care for ACS Patients Undergoing PCI with DES

The SMART-DATE trial recommends that ACS patients undergoing PCI with DES be treated with prolonged DAPT (at least 12 months) rather than short-term...

Long Term Treatment with Riociguat Sustains Clinical Benefits for upto One Year in CTPH

Long-term treatment with riociguat had a favorable benefit-risk profile in patients with inoperable chronic thromboembolic pulmonary hypertension (...

VERDICT Trial: A Head-to-Head Comparison of Early vs. Standard Care Invasive Strategy in NTSE-ACS Patients

The VERDICT trial compared the long-term clinical outcomes following an early invasive coronary evaluation strategy vs. the standard invasive...

Slide Library

Medical Management Strategy of CTEPH: Role of Riociguat

Riociguat, a stimulator of soluble guanylate cyclase, has been globally approved for the treatment of PAH and inoperable CTEPH and persistent/...

 
Email this page
Macitentan: 1st ERA Proven to Reduce Morbidity and Mortality in PAH

Macitentan is an orally active, potent, tissue targeting ERA that is indicated for the treatment of pulmonary arterial hypertension (PAH). It is the...

 
Email this page
Chronic Thromboembolic Pulmonary Hypertension

Chronic thromboembolic pulmonary hypertension (CTEPH) is the presence of mean pulmonary artery pressure (mPAP) ≥ 25 mmHg following an episode of...

 
Email this page
Diabetic Dyslipidemia

Dyslipidemia is one of the key risk factors for cardiovascular disease (CVD) in diabetes mellitus. This slide set provides information on the...

 
Email this page

Our Publications

Mexohar (Mexiletine) Monograph

About 5% of patients with cardiac arrhythmias or with heart failure are diagnosed with a ventricular tachycardia. Recurrent Ventricular Tachycardia...

Gutron (Midodrine hydrochloride) Monograph

Orthostatic Hypotension is common in elderly (>70 years of age) and can also occur secondary to neuropathy like in diabetes or central lesions...

Azmarda (Sacubitril/Valsartan) FAQs

This booklet on frequently asked questions on sacubitril/valsartan, the first-in-class angiotensin receptor neprilysin inhibitor (ARNI) provides...

Retefast (Reteplase) Datasheet

This datasheet provides an overview on the pharmacology, clinical efficacy, safety, indications and dosage of reteplase.

Patient Education

Understanding Angioplasty

Angioplasty is a life-saving procedure to open up blocked or narrowed blood vessels. This document gives a brief idea about the procedure.

Understanding Obesity

This document explains what is obesity, what is the impact of obesity on overall health and what are the benefits of weight loss. 

Hypertension

Know more about the risk factors, associated ill-effects and tips for management of hypertension or high blood pressure. 

Poll

What percent of your patients who need oral anticoagulation, receive warfarin?
<20%
26% (5 votes)
20-40%
16% (3 votes)
40-50%
11% (2 votes)
50-70%
16% (3 votes)
70-80%
26% (5 votes)
Almost all
5% (1 vote)
Total votes: 19